Likewise, Figure 4(b) illustrates that the MPO activity was significantly increased in the P-WPS (181.9 ± 4.4 U/mg, P < 0.0001), AF-WPS (151.8 ± 4.8 U/mg, P < 0.05), and SF-WPS (201.5 ± 2.0 U/mg, P < 0.0001) groups compared with the control ones (135.7 ± 1.5 U/mg). The gene discussed is MPO; the disease is atrial fibrillation.